secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2026-01-28T23:59:59+00:00
Accession:  0001683168-26-000589
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals appoints Vanessa Jacoby to board; Birnbaum retires as director
--------------------------------------------------------------------------------

- Dr. Jay Birnbaum retired from board Jan 28, 2026; will serve as consultant for one year, receiving 5,000 RSUs per quarter.
- Vanessa Jacoby appointed director effective Jan 28, replaces Birnbaum as independent director; will chair Audit Committee.
- Jacoby receives initial grant of options to purchase 10,000 shares vesting over 3 years; annual retainer $32,500 plus committee fees.
- Board amended director compensation plan to allow discretion in annual option grant size and form of initial equity grants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000589/0001683168-26-000589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316826000589/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer